Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Internal Medicine · SAN ANTONIO, TX · NPI 1821160938
Verified facts
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Payment overview · 2025
We did not find matching Open Payments records for this doctor in the selected program year.
Separate record types
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 610 | 218 |
| Levothyroxine Sodium | Levothyroxine Sodium | 441 | 154 |
| Lisinopril | Lisinopril | 410 | 145 |
| Amlodipine Besylate | Amlodipine Besylate | 382 | 151 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 318 | 117 |
| Losartan Potassium | Losartan Potassium | 315 | 124 |
| Metformin Hcl | Metformin Hcl | 262 | 105 |
| Gabapentin | Gabapentin | 202 | 84 |
| Montelukast Sodium | Montelukast Sodium | 201 | 75 |
| Omeprazole | Omeprazole | 200 | 77 |
| Hydrochlorothiazide | Hydrochlorothiazide | 194 | 72 |
| Simvastatin | Simvastatin | 184 | 72 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 164 | 44 |
| Alendronate Sodium | Alendronate Sodium | 160 | 54 |
| Pantoprazole Sodium | Pantoprazole Sodium | 159 | 61 |
| Metoprolol Succinate | Metoprolol Succinate | 156 | 69 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 138 | 53 |
| Carvedilol | Carvedilol | 134 | 53 |
| Metoprolol Tartrate | Metoprolol Tartrate | 133 | 50 |
| Furosemide | Furosemide | 128 | 55 |
| Trazodone Hcl | Trazodone Hcl | 117 | 49 |
| Glipizide Er | Glipizide | 108 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 108 | 46 |
| Fluticasone Propionate | Fluticasone Propionate | 107 | 49 |
| Jardiance | Empagliflozin | 104 | 39 |
| Nifedipine Er | Nifedipine | 101 | 37 |
| Tizanidine Hcl | Tizanidine Hcl | 95 | 39 |
| Tramadol Hcl | Tramadol Hcl | 92 | 36 |
| Eliquis | Apixaban | 84 | 35 |
| Alprazolam | Alprazolam | 83 | 18 |
| Escitalopram Oxalate | Escitalopram Oxalate | 81 | 25 |
| Pravastatin Sodium | Pravastatin Sodium | 81 | 33 |
| Chlorthalidone | Chlorthalidone | 78 | 29 |
| Clopidogrel | Clopidogrel Bisulfate | 72 | 32 |
| Mounjaro | Tirzepatide | 70 | 15 |
| Glipizide | Glipizide | 69 | 28 |
| Potassium Chloride | Potassium Chloride | 66 | 26 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 65 | 19 |
| Meloxicam | Meloxicam | 63 | 31 |
| Citalopram Hbr | Citalopram Hydrobromide | 62 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 61 | 26 |
| Metformin Hcl Er | Metformin Hcl | 60 | 25 |
| Lovastatin | Lovastatin | 59 | 18 |
| Spironolactone | Spironolactone | 58 | 24 |
| Lorazepam | Lorazepam | 55 | 20 |
| Glimepiride | Glimepiride | 53 | 19 |
| Farxiga | Dapagliflozin Propanediol | 52 | 21 |
| Sertraline Hcl | Sertraline Hcl | 52 | 19 |
| Buspirone Hcl | Buspirone Hcl | 50 | 17 |
| Enalapril Maleate | Enalapril Maleate | 50 | 19 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 50 | 38 |
| Finasteride | Finasteride | 49 | 18 |
| Myrbetriq | Mirabegron | 49 | 18 |
| Pioglitazone Hcl | Pioglitazone Hcl | 49 | 19 |
| Allopurinol | Allopurinol | 46 | 18 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 46 | 16 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 44 | 16 |
| Ibuprofen | Ibuprofen | 41 | 22 |
| Rybelsus | Semaglutide | 41 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 39 | suppressed |
| Famotidine | Famotidine | 38 | 14 |
| Ozempic | Semaglutide | 36 | 11 |
| Atenolol | Atenolol | 35 | 14 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 35 | 11 |
| Ondansetron Odt | Ondansetron | 35 | 17 |
| Azithromycin | Azithromycin | 34 | 30 |
| Trulicity | Dulaglutide | 34 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 34 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 33 | 15 |
| Oxybutynin Chloride | Oxybutynin Chloride | 31 | 15 |
| Prednisone | Prednisone | 31 | 23 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 29 | 15 |
| Mirtazapine | Mirtazapine | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 25 |
| Clonazepam | Clonazepam | 27 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 25 | 15 |
| Fluconazole | Fluconazole | 24 | 14 |
| Januvia | Sitagliptin Phosphate | 24 | suppressed |
| Nystatin | Nystatin | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 19 |
| Symbicort | Budesonide/Formoterol Fumarate | 24 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 23 | 15 |
| Colchicine | Colchicine | 23 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 23 | 13 |
| Topiramate | Topiramate | 23 | suppressed |
| Methylprednisolone | Methylprednisolone | 22 | 20 |
| Amiodarone Hcl | Amiodarone Hcl | 21 | suppressed |
| Fenofibrate | Fenofibrate | 21 | suppressed |
| Mupirocin | Mupirocin | 21 | 17 |
| Paxlovid | Nirmatrelvir/Ritonavir | 21 | 21 |
| Cephalexin | Cephalexin | 20 | 18 |
| Doxycycline Hyclate | Doxycycline Hyclate | 20 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 20 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | 11 |
| Nitroglycerin | Nitroglycerin | 20 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 19 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 18 | suppressed |
| Eszopiclone | Eszopiclone | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Xarelto | Rivaroxaban | 17 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 17 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Baclofen | Baclofen | 15 | 11 |
| Candesartan Cilexetil | Candesartan Cilexetil | 15 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 15 | suppressed |
| Naproxen | Naproxen | 15 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 14 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 14 | 12 |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Celecoxib | Celecoxib | 13 | suppressed |
| Ezetimibe | Ezetimibe | 13 | suppressed |
| Levetiracetam | Levetiracetam | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 13 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 12 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 12 | suppressed |
| Synthroid | Levothyroxine Sodium | 12 | suppressed |
| Telmisartan | Telmisartan | 12 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 12 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Incontrol Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Lubiprostone | Lubiprostone | 11 | suppressed |
| Memantine Hcl | Memantine Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
Timeline
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error